EC Number | Application | Comment | Organism |
---|---|---|---|
1.14.14.32 | medicine | inhibition of EC 4.1.2.30 is a potential therapeutic approach for the treatment of both breast and prostrate cancers | Macaca fascicularis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.32 | additional information | overview | Macaca fascicularis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.14.32 | Macaca fascicularis | - |
cynomolgus monkey | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.14.32 | testis | - |
Macaca fascicularis | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.32 | 17alpha-Hydroxypregnenolone | - |
Macaca fascicularis | Dehydroepiandrosterone + acetaldehyde | DHEA | ? | |
1.14.14.32 | 17alpha-hydroxyprogesterone + [reduced NADPH-hemoprotein reductase] + O2 | - |
Macaca fascicularis | androstenedione + acetate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |